Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
New GPC Inc. is recalling Alcosulph Moisturizing Cream because it lacks required OTC drug listings and labeling, and is marked not approved for sale in the U.S.
New Gpc Inc. is recalling Mustarcreme units in New York because the product lacks required drug listings, OTC labeling, and is marked not approved for U.S. sale.
ZEE Medical is recalling ZEE Aspirin 325mg tablets because the product label incorrectly lists inactive ingredients.
New GPC Inc. is recalling 4,320 units of Whitfield's Ointment B.P. in New York due to missing drug listings and non-compliant labeling.
New GPC Inc. is recalling Alcosulph Astringent Lotion because it lacks required drug listings and OTC labeling, and is labeled as not approved for sale in the U.S.
American Health Packaging is recalling 2,005 cartons of Methylprednisolone 4 mg tablets because they failed to meet potency standards at a 6-month stability time point.
Hospira is recalling 109,110 vials of Lidocaine Hydrochloride Injection because the product was discolored and contained visible particulates.
Unit Dose Solutions Inc is recalling 1,177 packets of Atorvastatin Calcium 40 MG tablets because 179 doses of Valacyclovir HCl 500 mg tablets were found repacked in the unit dose packs.
Valeant Pharmaceuticals is recalling 34,218 tubes of Hydrocortisone Butyrate Cream 0.1% because the product failed stability testing for potency and preservative levels.
Valeant Pharmaceuticals is recalling 1,663 tubes of Locoid cream because the active ingredient and preservatives were subpotent at the 18-month stability test point.
Zydus Pharmaceuticals is recalling Topiramate 200 mg tablets because 100 mg tablets were found mixed in the bottles.
Gyma Laboratories of America, Inc. is recalling Clonidine Base Micronized due to lack of good manufacturing practices identified by the Italian Medicines Agency.
Sagent Pharmaceuticals is recalling specific lots of Ketorolac Tromethamine Injection because the products were labeled with incorrect expiration dates.
Gyma Laboratories of America, Inc. is recalling Propranolol HCl due to lack of good manufacturing practices identified by the Italian Medicines Agency.
Gyma Laboratories of America, Inc. is recalling Dipyridamole API due to lack of good manufacturing practices identified by the Italian Medicines Agency.
Avella of Deer Valley, Inc. is recalling 197 vials of Hydroxyprogesterone Caproate 250 mg/mL injectable because crystals were observed in the product.
Gyma Laboratories of America, Inc. is recalling Clonidine HCL chemical product for medicines preparation due to lack of good manufacturing practices.
Valeant Pharmaceuticals is recalling 205,853 bottles of Vasotec (enalapril maleate) tablets because they were packaged with the incorrect version of the package insert.
Valeant Pharmaceuticals is recalling Vaseretic tablets because they were packaged with the incorrect version of the package insert.
Unique Pharmaceutical, Ltd is recalling one lot of N-Acetyl Cysteine 20% vials because testing revealed the presence of Herbaspirillum huttiense bacteria.
Unique Pharmaceutical, Ltd is recalling all sterile products due to poor aseptic production practices identified by an FDA inspection.
Janssen Ortho L.L.C. is recalling 13,500 bottles of Xarelto (rivaroxaban) 15 mg tablets due to confirmed microbial contamination in a sales sample.
Zydus Pharmaceuticals is recalling 5,400 bottles of Atenolol 25 mg tablets nationwide after a pharmacist reported that several tablets appeared noticeably thicker.
Mylan Pharmaceuticals is recalling 15,966 bottles of Metoprolol Succinate Extended-release Tablets 50mg because a pharmacist reported finding a rogue tablet of different size and markings in a bottle.
Mylan Institutional LLC is recalling Amiodarone HCl Injection due to inadvertent refrigeration during distribution. McKesson distributed the affected vials to facilities in WA, OR, and MT.